Yahoo Canada Web Search

Search results

    • Phio Pharmaceuticals Announces Reverse Stock Split

      Fairview Post· 5 days ago

      (Nasdaq: PHIO) (the “Company”), a clinical stage biotechnology company whose proprietary INTASYL...effective in killing tumor cells, today announced that the Company’s Board of Directors has ...

    • Friday’s analyst upgrades and downgrades

      Friday’s analyst upgrades and downgrades

      The Globe and Mail· 2 days ago

      (ATZ-T) to $42 from $40 ahead of the retailer’s fiscal first quarter 2025 results after markets close on July 11. For the quarter, Canaccord is ...